Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer

Kazuhiro Noma, Hajime Kashima, Takayuki Ninomiya, Ryoichi Katsube, Shinichiro Watanabe, Toshiaki Ohara, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Advances in molecular and cellular biochemistry, such as the development of targeted cancer therapy, have dramatically improved the prognosis of cancer patients. Emerging data have suggested that bevacizumab treatment may act by controlling the cancer microenvironment. Many reports have examined the interaction of cancer cells with the tumor microenvironment, and cancer-associated fibroblasts (CAF5) are thought to play a central role in this process. We speculated that the cancer microenvironment and in particular, CAFs, strongly influence the development of esophageal cancer. We have analyzed the signaling pathways of molecular targets. However, inhibition of a single signaling pathway is insufficient to treat cancer effectively. Photoimmunotherapy is a molecular-targeted specific cancer therapy using near-infrared radiation, which was introduced by Mitsunaga et al. in 2011. We are using its specific method of killing cells to target CAFs. We will report the results of its effect on cancer cells in the future.

Original languageEnglish
Pages (from-to)1228-1230
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume42
Issue number10
Publication statusPublished - Oct 1 2015

Fingerprint

Esophageal Neoplasms
Tumor Microenvironment
Neoplasms
Therapeutics
Cell Communication
Biochemistry
Cancer-Associated Fibroblasts
Radiation

Keywords

  • Cancer-associated fibroblast
  • Photo-immunotherapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer. / Noma, Kazuhiro; Kashima, Hajime; Ninomiya, Takayuki; Katsube, Ryoichi; Watanabe, Shinichiro; Ohara, Toshiaki; Tazawa, Hiroshi; Kagawa, Shunsuke; Shirakawa, Yasuhiro; Fujiwara, Toshiyoshi.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 42, No. 10, 01.10.2015, p. 1228-1230.

Research output: Contribution to journalArticle

@article{497e05a0f80d4bedb8b84adc92241da4,
title = "Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer",
abstract = "Advances in molecular and cellular biochemistry, such as the development of targeted cancer therapy, have dramatically improved the prognosis of cancer patients. Emerging data have suggested that bevacizumab treatment may act by controlling the cancer microenvironment. Many reports have examined the interaction of cancer cells with the tumor microenvironment, and cancer-associated fibroblasts (CAF5) are thought to play a central role in this process. We speculated that the cancer microenvironment and in particular, CAFs, strongly influence the development of esophageal cancer. We have analyzed the signaling pathways of molecular targets. However, inhibition of a single signaling pathway is insufficient to treat cancer effectively. Photoimmunotherapy is a molecular-targeted specific cancer therapy using near-infrared radiation, which was introduced by Mitsunaga et al. in 2011. We are using its specific method of killing cells to target CAFs. We will report the results of its effect on cancer cells in the future.",
keywords = "Cancer-associated fibroblast, Photo-immunotherapy, Tumor microenvironment",
author = "Kazuhiro Noma and Hajime Kashima and Takayuki Ninomiya and Ryoichi Katsube and Shinichiro Watanabe and Toshiaki Ohara and Hiroshi Tazawa and Shunsuke Kagawa and Yasuhiro Shirakawa and Toshiyoshi Fujiwara",
year = "2015",
month = "10",
day = "1",
language = "English",
volume = "42",
pages = "1228--1230",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "10",

}

TY - JOUR

T1 - Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer

AU - Noma, Kazuhiro

AU - Kashima, Hajime

AU - Ninomiya, Takayuki

AU - Katsube, Ryoichi

AU - Watanabe, Shinichiro

AU - Ohara, Toshiaki

AU - Tazawa, Hiroshi

AU - Kagawa, Shunsuke

AU - Shirakawa, Yasuhiro

AU - Fujiwara, Toshiyoshi

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Advances in molecular and cellular biochemistry, such as the development of targeted cancer therapy, have dramatically improved the prognosis of cancer patients. Emerging data have suggested that bevacizumab treatment may act by controlling the cancer microenvironment. Many reports have examined the interaction of cancer cells with the tumor microenvironment, and cancer-associated fibroblasts (CAF5) are thought to play a central role in this process. We speculated that the cancer microenvironment and in particular, CAFs, strongly influence the development of esophageal cancer. We have analyzed the signaling pathways of molecular targets. However, inhibition of a single signaling pathway is insufficient to treat cancer effectively. Photoimmunotherapy is a molecular-targeted specific cancer therapy using near-infrared radiation, which was introduced by Mitsunaga et al. in 2011. We are using its specific method of killing cells to target CAFs. We will report the results of its effect on cancer cells in the future.

AB - Advances in molecular and cellular biochemistry, such as the development of targeted cancer therapy, have dramatically improved the prognosis of cancer patients. Emerging data have suggested that bevacizumab treatment may act by controlling the cancer microenvironment. Many reports have examined the interaction of cancer cells with the tumor microenvironment, and cancer-associated fibroblasts (CAF5) are thought to play a central role in this process. We speculated that the cancer microenvironment and in particular, CAFs, strongly influence the development of esophageal cancer. We have analyzed the signaling pathways of molecular targets. However, inhibition of a single signaling pathway is insufficient to treat cancer effectively. Photoimmunotherapy is a molecular-targeted specific cancer therapy using near-infrared radiation, which was introduced by Mitsunaga et al. in 2011. We are using its specific method of killing cells to target CAFs. We will report the results of its effect on cancer cells in the future.

KW - Cancer-associated fibroblast

KW - Photo-immunotherapy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84962304172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962304172&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 1228

EP - 1230

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 10

ER -